Lithium carbonate - Bipolar disorder (adults)
You are here : Home > Formulary Search > Lithium carbonate - Bipolar disorder (adults)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Modified release tablets
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Initiation and stabilisation by the specialist mental health team for at least 1 month before any request to transfer prescribing responsibility to primary care.
SASH- (Tablets non-formulary)
Documentation
Information
PAD Profile
ChemicalSubstance :
Lithium carbonate
Indication :
Bipolar disorder (adults)
Group Name :
Keywords :
Brand Names Include :
Priadel, Camcolit, Liskonum
Important Information :
Prescribe by BRAND. Lithium carbonate and lithium citrate are not equivalent.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (1)
The Surrey & North West Sussex Area Prescribing Committee agreed the BLUE information sheet for lithium.
Other Indications
Below are listed other indications that Lithium carbonate is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Bipolar disorder (adults).